Directorate Change

RNS Number : 8187F
Revolution Beauty Group PLC
09 November 2022
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

For Immediate Release

 09 November 2022

 

 

REVOLUTION BEAUTY GROUP PLC

("Revolution Beauty", the "Group" or the "Company")

 

Directorate Change

The Board of Revolution Beauty today announces that as a result of the events since IPO and the transition from a private company to a public company, CEO Adam Minto has resigned as a Director of the Group and stepped down from the business with immediate effect.

As previously announced on 14 October 2022, Mr Minto stepped away from the day-to-day management of the business in order to support the independent investigation being carried out by Forensic Risk Alliance and Macfarlanes. Mr Minto has stated that he will continue to support the investigation through to its conclusion.

Bob Holt OBE has been responsible for the day-to-day running of Revolution Beauty since that date and remains as interim Chief Operating Officer.

The Board of Revolution Beauty reiterates that the independent investigation being carried out by Forensic Risk Alliance and Macfarlanes remains ongoing, and no conclusions have been drawn.

- Ends-

For further information please contact:


Revolution Beauty Investor Relations


Bob Holt / Elizabeth Lake

Investor.Relations@revolutionbeautyplc.com


 

J oint Corporate Brokers

 

 

Zeus (NOMAD): Nick Cowles /Jamie Peel /Jordan Warburton  

Liberum: Clayton Bush / Edward Thomas / Miquela Bezuidenhoudt

 

Tel: +44 (0) 161 831 1512

 

Tel: +44 (0) 203 100 2222

 

Media enquiries:

Headland Consultancy

Rosh Field / Will Smith / Marta Parry-Jones

Tel: +44 (0)20 3805 4822

Revolutionbeauty@headlandconsultancy.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPGQAGUPPURB
UK 100

Latest directors dealings